Volume 12, Issue 1 (1-2024)
J. Pediatr. Rev 2024, 12(1): 1-4 |
Back to browse issues page
1- Thalassemia Research Center, Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran. , dr.naderisorki@gmail.com
2- Psychiatry and Behavioral Sciences Research Center, Addiction Institute, Mazandaran University of Medical Sciences, Sari, Iran.
3- Research Laboratory of Intelligent Wireless Networks, Faculty of Engineering, Shahid Chamran University of Ahvaz, Ahvaz, Iran.
2- Psychiatry and Behavioral Sciences Research Center, Addiction Institute, Mazandaran University of Medical Sciences, Sari, Iran.
3- Research Laboratory of Intelligent Wireless Networks, Faculty of Engineering, Shahid Chamran University of Ahvaz, Ahvaz, Iran.
Abstract: (826 Views)
Since Alan Turing proposed the concept of using computers for intelligent simulation of behavior and critical thinking, artificial intelligence has progressed in various fields. In medicine, artificial intelligence is used in three subfields: Machine learning (ML), deep learning (DL), and computer vision. Considering the increasing use of artificial intelligence in pediatric oncology and cancer treatment, there is a need for studies and research projects specifically focused on pediatric oncology. In oncology, especially childhood malignancies, artificial intelligence can help doctors as a new tool.
Type of Study: Letter to the Editor |
Subject:
Pediatric Hematology and Oncology
Received: 2023/06/21 | Accepted: 2023/11/11 | Published: 2024/01/1
Received: 2023/06/21 | Accepted: 2023/11/11 | Published: 2024/01/1
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |